Financials data is unavailable for this security.
View more
Year on year ICU Medical Inc had revenues remain flat at 2.28bn, though the company grew net income from a loss of 74.29m to a smaller loss of 29.66m. A reduction in the cost of goods sold as a percentage of sales from 69.40% to 67.25% was a component in the net income growth despite flat revenues.
| Gross margin | 32.87% |
|---|---|
| Net profit margin | -4.74% |
| Operating margin | -0.30% |
| Return on assets | -2.56% |
|---|---|
| Return on equity | -5.35% |
| Return on investment | -2.90% |
More ▼
Cash flow in USDView more
In 2023, ICU Medical Inc increased its cash reserves by 21.76%, or 45.44m. The company earned 166.20m from its operations for a Cash Flow Margin of 7.36%. In addition the company used 87.95m on investing activities and also paid 35.98m in financing cash flows.
| Cash flow per share | 4.69 |
|---|---|
| Price/Cash flow per share | 36.20 |
| Book value per share | 83.76 |
|---|---|
| Tangible book value per share | -8.81 |
More ▼
Balance sheet in USDView more
| Current ratio | 2.29 |
|---|---|
| Quick ratio | 1.03 |
| Total debt/total equity | 0.7799 |
|---|---|
| Total debt/total capital | 0.4382 |
More ▼
Growth rates in USD
Year on year, growth in earnings per share excluding extraordinary items increased 60.45%.
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -289.73 |
